Boeing’s Order Surge Faces Regulatory Hurdles

Boeing finds itself navigating a complex set of circumstances. Despite a remarkable surge in new orders during November that significantly outpaced European rival Airbus, fresh regulatory scrutiny is creating investor uncertainty. The critical issue for the market is whether robust commercial performance can offset renewed certification delays for the pivotal 737 MAX program.

Operational Momentum Offsets Concerns

The resilience of Boeing’s share price, which closed up approximately 2% at 174.44 euros on Friday, can be attributed to surprisingly strong operational results. The company has recently overtaken Airbus in the race for new orders scheduled for 2025. Data from November provides clear evidence of this commercial strength:

• Deliveries: The aerospace giant handed over 44 commercial aircraft.
• Gross Orders: The firm secured 164 new gross orders.
• Order Backlog: After accounting for cancellations, a net total of 126 aircraft were added, solidifying the overall backlog at over 6,000 units.

Increasing demand for wide-body aircraft, specifically the 787 and 777X models, is providing substantial support. These high-margin programs help cushion the financial impact stemming from delays within the narrow-body segment.

Persistent Regulatory Scrutiny

The stock’s stability is notable given concerning developments from regulatory authorities in Washington. The Federal Aviation Administration (FAA) has formally announced a review of the crew alerting system for the 737 MAX 10.

Should investors sell immediately? Or is it worth buying Boeing?

This move carries a dual meaning: while it implies heightened short-term oversight, it also signals tangible progress in the certification pathway for the largest MAX variant. News regarding the smaller MAX 7 is less encouraging. Southwest Airlines CEO Bob Jordan recently tempered expectations, projecting certification will not occur until August 2026, which likely pushes commercial service into early 2027.

A Path to Financial Recovery?

Management’s forward guidance is bolstering confidence alongside the order figures. Chief Financial Officer Jay Malave has projected that Boeing will generate positive free cash flow in the low single-digit billions for 2026. This forecast proved crucial in reversing the pessimistic sentiment that prevailed last quarter. The leadership team maintains its medium-term target of achieving $10 billion in annual free cash flow.

Market analysts are responding positively to this trajectory. Banking giant UBS reaffirmed its “Buy” rating with a price target of $275. The firm’s experts are betting on successful production ramp-ups and the eventual overcoming of remaining MAX certification obstacles.

The current share price suggests investors are willing to look past timeline shifts, provided airline demand remains as robust as it was in November. The key determinant for Boeing’s future performance will now be its ability to reliably meet the newly revised schedules for the MAX 7 and MAX 10 variants.